EXHIBIT 107
Calculation of Filing Fee Table
Form S-3
(Form Type)
Lexaria Bioscience Corp.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
|
| Security Type |
| Security Class Title |
| Fee Calculation Rule |
|
| Amount Registered |
|
| Proposed Maximum Offering Price Per Unit |
|
| Proposed Maximum Aggregate Offering Price |
|
| Fee Rate |
|
| Amount of Registration Fee |
| ||||||
Fees to be paid |
| Equity |
| Common Stock, par value $0.001 per share |
|
| 457 | (c) |
|
| 4,551,019 | (1) |
| $ | 2.115 | (2) |
| $ | 9,625,405.185 |
|
| $ | 0.00015310 |
|
| $ | 1,473.65 |
|
|
|
|
| Total Offering Amounts |
|
| 0 |
|
|
| 0 |
|
|
| 0 |
|
| $ | 9,625,405.185 |
|
|
| 0 |
|
| $ | 1,473.65 |
|
|
|
|
| Total Fee Offsets |
|
| 0 |
|
|
| 0 |
|
|
| 0 |
|
|
| -- |
|
|
| 0 |
|
|
| -- |
|
|
|
|
| Net Fee Due |
|
| 0 |
|
|
| 0 |
|
|
| 0 |
|
|
| 0 |
|
|
| 0 |
|
| $ | 1,473.65 |
|
(1) | Shares of common stock will be offered for resale by the selling stockholder pursuant to the prospectus contained in the registration statement to which this exhibit is attached. The registration statement registers the resale of an aggregate of 4,551,019 shares of the registrant’s common stock. Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the shares of common stock being registered hereunder include an indeterminable number of additional shares of common stock that may be issuable as a result of stock splits, stock dividends or similar transactions. |
|
|
(2) | Determined pursuant to Rule 457(c) under the Securities Act, solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the Company’s common stock on The Nasdaq Capital Market on November 22, 2024, which date is a date within five business days prior to the filing of this registration statement. |
Table 2: Fee Offset Claims and Sources
N/A
Table 3: Combined Prospectuses
N/A
